PRMT5 catalyzes the formation of symmetric dimethylation (SDMA) by transferring 1 or 2 methyl groups from S-adenosylmethionine to the guanidino nitrogen of protein arginine, thereby influencing tumor progression through multiple pathways [16–18]. This evidence concerns the gene PRMT5 and neoplasm.